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BACKGROUND-AIM
From the recent results of past researches, a possible virus infection association was found with the onset of allergic
sensitization in infants. Other investigations have shown both increased and decreased levels of IgE in association with
viral infections. The purpose of the present study was to examine more closely the relationship between viral infection
with SARS CoV-2 virus and IgE levels.
The host immune response to SARS CoV-2 can lead to an aberrant inflammatory response or “cytokine storm” which
contributes to the severity of illness.
Therefore, the host immune response plays a key role in the SARS CoV-2 pathogenesis and seems to be different
from other coronavirus infections owing to specific epigenetic-sensitive mechanisms unveiled in severe patients upon
interactions between SARS-CoV-2 and host cells.
METHODS
For this purpose, a retrospective study was performed on a population of patients with upper respiratory symptoms of
viral infection with SARS CoV-2 in the period of 01-31 December 2020.
Seventy two patients (n=72) with respiratory infection to SARS CoV-2 viral ugents were studied retrospectively with
respect to IgE immunoglobulin levels during acute (I to 7 days) and convalescent (8 to 30 days) phases of infection.
The” cytokine storm” was exploited to monitor the course of infection and in the study were considered patients with
high level of inflammatory biomarkers, including high levels of interleukin 6 (IL-6) (IL-6 > 40 pg/ml) and procalcitonin
(PCT) (PCT ≥ 0.5 ng/mL) with CLIA method, and plasma C-reactive protein (CRP) (CRP ≥ 10 mg/L) and ferritin (serum
ferritin>300 µg/l) with nephelometric method . Measurements of IgE level was obtained with CLIA method with normal
referent ranges of 1-87 IU/ml.
RESULTS
Analysis of changes of IgE levels for given individuals during acute and convalescent phases of SARS CoV-2 infection
was found that 59% of patients had an increase in IgE level of 20% or more, 14% showed a rise of less than 20% of
normal level and 27% were in the normal range.
Results showed more increasing levels of IgE in patients in acute phase, and increasing in convalescent phase was
linked with patients with more severity of inflammatory symptoms.
CONCLUSIONS
In the present study, it was found that SARS CoV-2 infection modulated serum IgE levels in both phases of the disease
in the infected individuals.
Since in preliminary studies for IgE antibodies to influenza and Epstein-Barr virus were detected in patients with those
viral infections, it is possible that the elevated IgE levels observed in the acute phase may be due, in part, to IgE
antibodies against the infectious agent and that these antibodies may be short-lived because of decreasing IgE levels
into the convalescent phase of infection.
Now, SARS CoV-2 is being clearly considered as novel hematologic disease, but the exact mechanistic role of both
innate and adaptive immunity against SARS-CoV-2 still needs to be clarified to help to find new targets.
